Virtu Financial LLC Ardelyx, Inc. Transaction History

Virtu Financial LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$6.05 - $9.74 $182,026 - $293,047	30,087 New	30,087 $220,000
Q2 2023 Jul 27, 2023	BUY	$3.23 - $4.95 $182,885 - $280,273	56,621 Added 153.76%	93,446 $317,000
Q1 2023 May 01, 2023	SELL	$2.68 - $4.79 $140,683 - $251,446	-52,494 Reduced 58.77%	36,825 $176,000
Q4 2022 Feb 15, 2023	BUY	$1.22 - $2.85 $23,234 - $54,278	19,045 Added 27.1%	89,319 $255,000
Q3 2022 Nov 07, 2022	BUY	$0.59 - $1.44 $41,461 - $101,194	70,274 New	70,274 $84,000
Q1 2022 May 17, 2022	SELL	$0.65 - $1.18 $185,820 - $337,334	-285,877 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.86 - $1.7 $245,854 - $485,990	285,877 New	285,877 $314,000
Q2 2021 Sep 17, 2021	SELL	$6.55 - $8.98 $114,435 - $156,889	-17,471 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$6.1 - $7.69 $62,403 - $78,668	-10,230 Reduced 36.93%	17,471 $116,000
Q4 2020 Feb 24, 2021	BUY	$5.05 - $7.1 $139,890 - $196,677	27,701 New	27,701 $179,000
Q3 2020 Dec 11, 2020	SELL	$5.25 - $7.08 $154,035 - $207,727	-29,340 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$5.37 - $8.11 $157,555 - $237,947	29,340 New	29,340 $203,000
Q4 2019 Feb 04, 2020	SELL	$4.23 - $8.29 $146,962 - $288,019	-34,743 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$2.15 - $6.28 $46,182 - $134,894	21,480 Added 161.95%	34,743 $163,000
Q2 2019 Aug 13, 2019	BUY	$2.49 - $3.73 $33,024 - $49,470	13,263 New	13,263 $36,000
Q1 2019 Apr 12, 2019	SELL	$1.88 - $3.35 $28,260 - $50,357	-15,032 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$1.66 - $4.16 $24,953 - $62,533	15,032 New	15,032 $27,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.